Q4 2010

Source filing unavailable

Q4 2010 · —

Revenue

$170.03M

+0.5% vs Q4 2009

Net Income

$20.99M

+429.9% vs Q4 2009

EPS Diluted

$0.81

no prior Q4 2009 on file

Gross Profit$87,501,000−0.7%

Operating Income$28,895,000+605.4%

Operating Cash Flowderived

Same quarter

Metric	Q4 2010	Q4 2009derived from reported figures
Revenue	$170.03M	$169.10M
Net Income	$20.99M	$3.96M
EPS Diluted	$0.81	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR